{"identifier":"nobleid:/w1/20260515/FC691663","arkIdentifier":"ark:/48914/w1/20260515/FC691663","version":1,"workTitle":"Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases.","workType":"Journal Article","authors":"C Chiodoni, A Stoppacciaro, S Sangaletti, G Gri, B Cappetti, Y Koezuka, M P Colombo","description":null,"workUrl":null,"existingDoi":"10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8","createdAt":"2026-05-15T12:49:28.970011Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260515/FC691663.v1"}